BMS-955176
Showing 1 - 25 of 819
Infection, Human Immunodeficiency Virus, HIV Trial in Berlin (BMS-955176, Placebo matching with BMS-955176, Atazanavir)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- BMS-955176
- +5 more
-
Berlin, GermanyGSK Investigational Site
Nov 4, 2019
HIV Trial in Austin (CYP and transporter probe substrates, BMS-955176, BMS-955176 plus CYP and transporter probe substrates)
Completed
- HIV Infections
- CYP and transporter probe substrates
- +2 more
-
Austin, TexasGSK Investigational Site
Jul 11, 2018
HIV Trial in Madison (BMS-955176)
Completed
- HIV Infections
- BMS-955176
-
Madison, WisconsinGSK Investigational Site
Apr 13, 2018
Infection, Human Immunodeficiency Virus Trial (BMS-955176, Ortho Cyclen)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-955176
- Ortho Cyclen
- (no location specified)
Apr 13, 2018
HIV Trial in Woburn (BMS-955176)
Completed
- HIV Infections
- BMS-955176
-
Woburn, MassachusettsGSK Investigational Site
Apr 13, 2018
Calcium Citrate Absorption, Calcium Carbonate Absorption Trial in Alexandria (The absorption effect between calcium citrate and
Not yet recruiting
- Calcium Citrate Absorption
- Calcium Carbonate Absorption
- The absorption effect between calcium citrate and calcium carbonate
-
Alexandria, EgyptThe surgical department of Medical Research Institute Hospital,
Sep 15, 2023
Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)
Not yet recruiting
- Burning Mouth Syndrome
- topical placebo tablet
- +5 more
- (no location specified)
Sep 10, 2023
Pulmonary Fibrosis Trial in Worldwide (BMS-986278 Placebo, BMS-986278)
Active, not recruiting
- Pulmonary Fibrosis
- BMS-986278 Placebo
- BMS-986278
-
Birmingham, Alabama
- +118 more
Dec 3, 2022
Burning Mouth Syndrome Trial in Catania (Diazepam 1% oral gel, Placebo)
Recruiting
- Burning Mouth Syndrome
- Diazepam 1% oral gel
- Placebo
-
Catania, ItalyAOU Policlinico G. Rodolico
May 23, 2023
Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Relapsed and/or Refractory Multiple Myeloma
- BMS-986453
- +2 more
-
Köln, GermanyLocal Institution - 0017
Dec 4, 2023
Infection, Human Immunodeficiency Virus Trial in Worldwide (BMS-955176, EFV, TDF/FTC)
Terminated
- Infection, Human Immunodeficiency Virus
- BMS-955176
- +2 more
-
Beverly Hills, California
- +63 more
Aug 20, 2018
Progressive Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)
Not yet recruiting
- Progressive Pulmonary Fibrosis
- BMS-986278
- BMS-986278 Placebo
-
Stanford, California
- +7 more
Sep 11, 2023
Idiopathic Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- BMS-986278
- BMS-986278 Placebo
-
Birmingham, Alabama
- +442 more
Aug 15, 2023
Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Palo Alto, California
- +7 more
Oct 10, 2023
Healthy Participants Trial in Cypress (BMS-986446, Placebo)
Not yet recruiting
- Healthy Participants
- BMS-986446
- Placebo
-
Cypress, CaliforniaAltasciences
Oct 10, 2023
Diabetic Foot Trial in Durham (Bluedrop Monitoring Service (BMS))
Not yet recruiting
- Diabetic Foot
- Bluedrop Monitoring Service (BMS)
-
Durham, North CarolinaDuke Clinical Research Institute
Sep 12, 2023
Healthy Volunteers Trial in City (BMS-986325, Placebo)
Not yet recruiting
- Healthy Volunteers
- BMS-986325
- Placebo
-
City, State, JapanLocal Institution
Apr 3, 2023
Relapsed or Refractory T-cell Lymphomas Trial in Sendai-shi (BMS-986369)
Not yet recruiting
- Relapsed or Refractory T-cell Lymphomas
-
Sendai-shi, Miyagi, JapanLocal Institution - 0001
Sep 12, 2023